Page last updated: 2024-11-05

ici 204,219 and Pulmonary Disease, Chronic Obstructive

ici 204,219 has been researched along with Pulmonary Disease, Chronic Obstructive in 4 studies

zafirlukast: a leukotriene D4 receptor antagonist

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"In both asthmatic and COPD patients, the overall effect of salmeterol and zafirlukast on the forced expiratory volume in 1 s (FEV1) was considered extremely significant (p < 0."2.70Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. ( Allegra, L; Boveri, B; Cazzola, M; Centanni, S; Di Marco, F; Matera, MG; Santus, P, 2001)
"New drugs and new approaches of the treatment of chronic obstructive pulmonary disease (COPD) are needed."2.45Targeting leukotrienes for the treatment of COPD? ( Drakatos, P; Karkoulias, K; Lykouras, D; Sampsonas, F; Spiropoulos, K, 2009)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Drakatos, P1
Lykouras, D1
Sampsonas, F1
Karkoulias, K1
Spiropoulos, K1
Bu, X1
Wang, C1
Pang, B1
Nannini, LJ1
Flores, DM1
Cazzola, M1
Centanni, S1
Boveri, B1
Di Marco, F1
Santus, P1
Matera, MG1
Allegra, L1

Reviews

1 review available for ici 204,219 and Pulmonary Disease, Chronic Obstructive

ArticleYear
Targeting leukotrienes for the treatment of COPD?
    Inflammation & allergy drug targets, 2009, Volume: 8, Issue:4

    Topics: 5-Lipoxygenase-Activating Proteins; Acetates; Arachidonate 5-Lipoxygenase; Bronchoconstriction; Capi

2009

Trials

2 trials available for ici 204,219 and Pulmonary Disease, Chronic Obstructive

ArticleYear
Bronchodilator effect of zafirlukast in subjects with chronic obstructive pulmonary disease.
    Pulmonary pharmacology & therapeutics, 2003, Volume: 16, Issue:5

    Topics: Administration, Oral; Aged; Albuterol; Bronchodilator Agents; Female; Humans; Indoles; Lung; Male; M

2003
Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Respiration; international review of thoracic diseases, 2001, Volume: 68, Issue:5

    Topics: Adrenergic beta-Agonists; Adult; Aged; Albuterol; Asthma; Bronchi; Bronchodilator Agents; Cross-Over

2001

Other Studies

1 other study available for ici 204,219 and Pulmonary Disease, Chronic Obstructive

ArticleYear
Effects of leukotriene receptor antagonist on chronic obstructive [correction of obstractive] pulmonary disease induced pulmonary hypertension.
    Chinese medical journal, 2003, Volume: 116, Issue:3

    Topics: Aged; Female; Hemodynamics; Humans; Hypertension, Pulmonary; Indoles; Leukotriene Antagonists; Leuko

2003